Headlines of the Future: Addressing global challenges with science and innovation

Bayer and Mammoth Biosciences to collaborate on novel gene editing technology

U.S. FDA approves Xarelto™ to treat venous thromboembolism (VTE) and to prevent VTE in children

Bayer receives positive CHMP opinion for finerenone as a new treatment for adult patients with chronic kidney disease associated with type 2 diabetes